XEMBIFY 200 mg/mL
immune globulin subcutaneous, human-klhw · SOLUTION · GRIFOLS USA, LLC
XEMBIFY is a solution containing immune globulin subcutaneous, human-klhw at 200 mg/mL, taken subcutaneous. Manufactured by GRIFOLS USA, LLC.
Key Facts
- Brand Name
- XEMBIFY
- Generic Name
- immune globulin subcutaneous, human-klhw
- NDC Code (Product)
13533-810- Manufacturer
- GRIFOLS USA, LLC
- Strength
- 200 mg/mL
- Dosage Form
- SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125683
- Marketing Start
- 07/03/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is XEMBIFY used for?
XEMBIFY contains immune globulin subcutaneous, human-klhw. It is a solution taken subcutaneous. Consult your doctor for specific uses.
Is XEMBIFY a controlled substance?
XEMBIFY is not classified as a controlled substance by the DEA.
What is the generic name for XEMBIFY?
The generic name for XEMBIFY is immune globulin subcutaneous, human-klhw. There are no other listed brand versions of immune globulin subcutaneous, human-klhw.
What is the NDC code for XEMBIFY 200 mg/mL?
The NDC (National Drug Code) for XEMBIFY 200 mg/mL is 13533-810, listed by GRIFOLS USA, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)